Sandra Michel El-Hachem MD
Inflammatory Bowel Disease
Associate Professor of Medicine, Drexel University School of Medicine Director of Inflammatory Bowel Disease Center Allegheny Health Network
Join to View Full Profile
1307 Federal StSte B100Pittsburgh, PA 15212
Phone+1 412-359-8900
Fax+1 412-358-8977
Dr. El-Hachem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sandra El-Hachem, MD, is a Gastroenterologist based in Pittsburgh, PA, with a subspecialty in Inflammatory Bowel Disease. Her training includes a medical degree from the American University of Beirut, a residency at the Cleveland Clinic Foundation, and a fellowship in Gastroenterology at the University of Pittsburgh Medical Center. She is experienced in managing conditions such as inflammatory bowel diseases , microscopic colitis and eosinophilic GI disorders. Dr. El-Hachem has contributed to several publications, including three consensus guidelines in The Lancet. Her research has been cited multiple times, indicating a strong engagement with the academic community. She is currently an Associate Professor of Medicine at Drexel University School of Medicine.
Education & Training
UPMC Medical EducationFellowship, Gastroenterology, 2007 - 2010
Cleveland Clinic FoundationResidency, Internal Medicine, 2004 - 2007
American University of Beirut Faculty of MedicineClass of 2003
Certifications & Licensure
PA State Medical License 2007 - 2026
OH State Medical License 2004 - 2007
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Publications & Presentations
PubMed
- 7 citationsEfficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort...Gursimran S Kochhar, Aakash Desai, Francis A Farraye, Raymond K Cross, Sandra El-Hachem
Alimentary Pharmacology & Therapeutics. 2023-08-01 - 15 citationsManagement of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium.Ravi P Kiran, Gursimran S Kochhar, Revital Kariv, Douglas K Rex, Akira Sugita
The Lancet. Gastroenterology & Hepatology. 2022-09-01 - 49 citationsTreatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran Kochhar, David T. Rubin, Sunanda V. Kane, Udayakumar Navaneethan
The Lancet. Gastroenterology & Hepatology. 2021-11-10
Press Mentions
Biologics for Crohn's Go Head to HeadJune 13th, 2022- Antibiotics Heighten Risk for IBD in SeniorsMay 13th, 2022
- TNF Blockers Less Effective for Patients Developing IBD Later in LifeApril 1st, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
